cyc 202 has been researched along with Neurodegenerative Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, SF; Jia, LJ; Lou, XK; Lu, H; Luo, Y; Ma, ZW; Shen, SL; Wang, H; Wang, WY; Xue, QS; Yang, R; Yu, BW; Zhang, HH | 1 |
| Crews, LA; Gonzales, T; Kouznetsova, VL; Masliah, E; Overk, CR; Patrick, C; Paulino, A; Price, D; Rockenstein, E; Stocking, E; Tsigelny, IF; Wrasidlo, W | 1 |
| Camins, A; Canudas, AM; Crespo-Biel, N; Gutiérrez-Cuesta, J; Melchiorri, D; Nicoletti, F; Pallàs, M | 1 |
| Achim, CL; Crews, L; Desplats, P; Dumaop, W; Everall, IP; Masliah, E; Patrick, C; Rockenstein, E | 1 |
| Schmid, G; Strosznajder, JB; Wesierska-Gadek, J | 1 |
1 review(s) available for cyc 202 and Neurodegenerative Diseases
| Article | Year |
|---|---|
Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
Topics: Animals; Apoptosis; Brain Ischemia; Cell Cycle; Cyclin-Dependent Kinase 5; Humans; Kinetin; Neurodegenerative Diseases; Neurons; Protein Kinase Inhibitors; Purines; Roscovitine; Tumor Suppressor Protein p53 | 2006 |
4 other study(ies) available for cyc 202 and Neurodegenerative Diseases
| Article | Year |
|---|---|
Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
Topics: Animals; Cells, Cultured; Cyclin-Dependent Kinase 5; Hippocampus; Isoflurane; Maze Learning; Neurodegenerative Diseases; Neurons; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Purines; Rats; Rats, Sprague-Dawley; Roscovitine | 2014 |
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.
Topics: AIDS Dementia Complex; Animals; Antineoplastic Agents; Cyclin-Dependent Kinase 5; Dasatinib; Erlotinib Hydrochloride; Flavonoids; HIV Envelope Protein gp120; In Vitro Techniques; Indoles; Lapatinib; Mice; Mice, Transgenic; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Protein Kinase Inhibitors; Purines; Pyrimidines; Pyrroles; Quinazolines; Rats; Roscovitine; Sunitinib; Thiazoles | 2014 |
Regulation of GSK-3beta by calpain in the 3-nitropropionic acid model.
Topics: Amino Acid Chloromethyl Ketones; Aminophenols; Animals; Calpain; Caspases; Cell Survival; Cells, Cultured; Convulsants; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Maleimides; Mice; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nitro Compounds; Propionates; Purines; Rats; Roscovitine; Signal Transduction; Time Factors | 2010 |
Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.
Topics: Adult; Animals; Brain; Cyclin-Dependent Kinase 5; Female; Frontal Lobe; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Human Immunodeficiency Virus Proteins; Humans; Male; Mice; Middle Aged; Neurodegenerative Diseases; Phosphotransferases; Purines; Roscovitine; Signal Transduction; tau Proteins | 2011 |